Valid Ghana · FDA Ghana

QUAMFORT TABLETS

CLOMOPHENE CITRATE

FDA/SD.255-123441 CLOMOPHENE CITRATE 50MG

What it does

Clomophene is a medicine that helps with fertility issues by stimulating the ovaries to release eggs.

Commonly used for: infertility (difficulty getting pregnant), anovulation (not ovulating)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.255-123441
Registration date
2025-12-30
Expiry date
2030-12-31
Status
Valid
Active ingredient
CLOMOPHENE CITRATE
Dosage form
CLOMOPHENE CITRATE
Strength
50MG
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Venturo Healthcare
Applicant / LTR
STAR LIFE SCIENCES
Country of origin
INDIA
Manufacturer location
Plot No- 54-55, VPO Mohra, Ambala Cantt Ambala, Mohra, Haryana 133004, India

Source: Food and Drugs Authority · fetched 2026-05-08 08:00:16 · updated 2026-10-20 04:00:04

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Clomophene is a medicine that helps with fertility issues by stimulating the ovaries to release eggs.

What it treats

  • infertility (difficulty getting pregnant)
  • anovulation (not ovulating)

How it works

It works by encouraging the ovaries to produce and release eggs, which can help increase the chances of pregnancy.

Who it's for

This medicine is for women who have trouble ovulating and want to conceive.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: clomophene

Clomiphene is a selective estrogen receptor modulator (SERM) primarily used in the treatment of ovulatory dysfunction in women who are infertile. It acts by modulating estrogen receptors in the hypothalamus and pituitary gland, leading to increased gonadotropin release and subsequent stimulation of ovarian function. Clomiphene is commonly prescribed for conditions such as polycystic ovary syndrome (PCOS) and other forms of anovulation.

Indications

  • Anovulation
  • Infertility due to ovulatory dysfunction
  • Polycystic ovary syndrome (PCOS)

Dosage

Children: Refer to BNF for Children for specific dosing recommendations.

Adults: Refer to BNF for specific dosing recommendations.

Mechanism of action

Clomiphene works by binding to estrogen receptors in the hypothalamus, blocking endogenous estrogen from exerting its negative feedback on gonadotropin-releasing hormone (GnRH) secretion. This results in increased levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), promoting ovarian follicular development and ovulation.

Pharmacodynamics

Clomiphene has a biphasic action depending on the dose and duration of treatment. At low doses, it acts as an estrogen agonist, while at higher doses, it exhibits antagonist properties. This dual action helps induce ovulation by promoting the secretion of FSH and LH. Additionally, clomiphene may enhance the sensitivity of ovarian follicles to gonadotropins and improve the likelihood of ovulation.

Pharmacokinetics

Clomiphene is well-absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately 6 to 8 hours after oral administration. It has a long half-life, allowing for prolonged action, and is metabolized primarily in the liver. The drug is excreted in urine and feces, with a significant portion of the dose being eliminated as metabolites rather than unchanged drug.

Contra-indications

  • Pregnancy
  • Unexplained uterine bleeding
  • Ovarian cysts (non-functional)
  • Liver disease
  • Active thrombophlebitis or thromboembolic disorders

Adverse effects

  • Hot flashes
  • Nausea
  • Vomiting
  • Abdominal discomfort
  • Visual disturbances
  • Ovarian enlargement
  • Multiple pregnancies

Interactions

  • Anticoagulants - may enhance effects of anticoagulants
  • Thyroid hormones - may require adjustment of thyroid hormone doses
  • Corticosteroids - may affect corticosteroid metabolism

Precautions

  • Monitor liver function tests before and during treatment
  • Use with caution in patients with a history of endometriosis
  • Consider potential for multiple gestations
  • Monitor for signs of ovarian hyperstimulation syndrome

Pregnancy

Clomiphene should not be used during pregnancy due to its potential teratogenic effects.

Breast-feeding

Clomiphene is not recommended during breastfeeding due to potential effects on milk production.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

  • Tablets: 50 mg

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.